Hundreds of thousands of people with type 2 diabetes could benefit if the medicines regulator approves a new weekly jab which cuts the number of injections needed by 86 per cent.
The National Institute for Health and Care Excellence (Nice) has recommended a weekly treatment which reduces the annual number of insulin injections from 365 to 52. However, the treatment is yet to be approved by the Medicines and Healthcare Products Regulatory Agency (MHRA).